Zensar Technologies has scheduled its Q1FY27 earnings conference call for Thursday, July 30, 2026, at 8:30 AM IST. The event is designed to discuss the company's financial performance for the first quarter of fiscal year 2026-27 (Q1FY27) with investors and analysts. This announcement follows the company's earlier communication dated July 21, 2026, regarding the schedule of its Board meeting.

The Board of Directors is scheduled to meet on Wednesday, July 29, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The earnings call will provide management's perspective on the operational and financial outcomes approved during this session. Zensar Technologies notified the BSE Limited and National Stock Exchange of India Limited of these arrangements via a letter dated July 27, 2026.

Conference Call Details

The earnings call will be led by senior management, including Manish Tandon, Managing Director and CEO, and Pulkit Bhandari, CFO. Other senior management personnel are also expected to participate in the discussion. The call is being coordinated by Asian Markets — Securities — Institutional Equities.

Dial-In Information

Investors and analysts can access the call through universal dial-in numbers or region-specific lines provided by the coordinator. Participants are required to register via the Diamond Pass registration link prior to the event. The specific dial-in numbers are as follows:

• Universal: +91 22 6280 1317 / +91 22 7115 8218
• USA: 18667462133
• UK: 08081011573
• Hong Kong: 800964448
• Singapore: 8001012045

Regulatory Compliance

The announcement was issued by Anand Daga, Company Secretary of Zensar Technologies Limited, and digitally signed on July 27, 2026. The notice serves as an informational update to stakeholders regarding the timeline for accessing management commentary on the Q1FY27 results. No specific financial figures were disclosed in this scheduling notice; those details will be presented during the board-approved results release and subsequent conference call.

Zensar Technologies granted 6,28,502 options to eligible employees under its Zensar - Employees Stock Option Scheme 2025 (ESOP 2025) at an exercise price of ₹2 per option. The Nomination Remuneration Committee approved the grant during a meeting held on July 20, 2026. The options are convertible into 6,28,502 equity shares, each with a face value of ₹2, aligning employee interests with the company's performance.

The exercise price is fixed at the face value of the shares at the time of the grant. This pricing structure aims to align the interests of employees across levels with the performance of the company and its unlisted subsidiary companies, ensuring upside potential backed by individual and company performance.

The scheme is administered by the Nomination and Remuneration Committee, which acts as a Compensation Committee. Implementation occurs through a trust route, with the Zensar Employees Welfare Trust acquiring existing shares via secondary acquisition from the market.

After vesting, options may be exercised wholly or partially within a maximum period of five years from the date of respective vesting. The scheme complies with the SEBI (SBEB & SE) Regulations, 2021.

Key Details of ESOP 2025 Grant